HHS debuts ‘unprecedented’ initiative to ‘restore American leadership’ in clinical trials

Among the health department’s efforts is an expedited investigational new drug pilot program that would leverage collaborations with U.S. research institutions to reduce early trial timelines by as much as 12 months.